Cargando…

EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma

BACKGROUND: Ephrin receptors (Eph) and their ligands, called ephrins, function in various disease processes. However, the expression level and prognostic value of Eph/ephrins in lung adenocarcinoma (LUAD) are still unclear. METHODS: The Oncomine and GEPIA databases were used to explore the different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Mingming, Tong, Run, Zhang, Zhe, Wang, Tao, Liang, Chaonan, Zhou, Xiaoming, Hou, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513303/ https://www.ncbi.nlm.nih.gov/pubmed/34645436 http://dx.doi.org/10.1186/s12935-021-02226-x

Ejemplares similares

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2021)

Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
por: Zhao, Xiangyu, et al.
Publicado: (2022)

Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer
por: Jiao, Zonglin, et al.
Publicado: (2022)

Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
por: Wu, Xianbin, et al.
Publicado: (2021)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma
por: Zhu, Naiqiang, et al.
Publicado: (2020)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance
por: Chu, Ling-Yu, et al.
Publicado: (2022)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
por: Qin, Yuan, et al.
Publicado: (2022)

EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma
por: Hao, Yong-Ping, et al.
Publicado: (2021)

Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
por: Gao, Chundi, et al.
Publicado: (2018)

Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation
por: Deng, Huan, et al.
Publicado: (2021)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

Postponing tumor onset and tumor progression can be achieved by alteration of local tumor immunity
por: Mei, Yan, et al.
Publicado: (2021)

Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
por: Ma, Rong, et al.
Publicado: (2019)

Expression profile analysis of two antisense lncRNAs to improve prognosis prediction of colorectal adenocarcinoma
por: Shademan, Milad, et al.
Publicado: (2019)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma
por: Liu, Jiahua, et al.
Publicado: (2021)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
por: Hong, Weifeng, et al.
Publicado: (2020)

PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinoma
por: Zou, Wenbo, et al.
Publicado: (2021)

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients
por: Chen, Yangshan, et al.
Publicado: (2019)

HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
por: Luo, Rong-Zhen, et al.
Publicado: (2021)

A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis
por: Wang, Yanfang, et al.
Publicado: (2019)

Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019)

Integrative analysis of ceRNA network reveals functional lncRNAs associated with independent recurrent prognosis in colon adenocarcinoma
por: Mao, Yinling, et al.
Publicado: (2021)

Visual Maps Development: Reconsidering the Role of Retinal Efnas and Basic Principle of Map Alignment
por: Savier, Elise, et al.
Publicado: (2018)

The 1q21.3 region driver gene EFNA3 promotes disease progression via inhibition of lung adenocarcinoma cell apoptosis
por: Dong, Chenchen, et al.
Publicado: (2022)

Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia
por: Gu, Siyu, et al.
Publicado: (2020)

Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients
por: Huang, Biao, et al.
Publicado: (2020)

Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
por: Zhang, Han, et al.
Publicado: (2021)

B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
por: Lin, Anqi, et al.
Publicado: (2022)

Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation
por: Gong, Lian, et al.
Publicado: (2020)

Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study
por: Liu, JinHui, et al.
Publicado: (2020)

A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p6eirmoh1joaggmf4m6cci5ome